Limiting the duration of antibiotic therapy is an attractive stewardship intervention with the potential to improve patient outcomes. However, applying this intervention to the SOT population is complicated by prevailing prescribing cultures and lack of data. #IDtwitter
@Willeeuhmm@TransplantIDNet@StanfordASP 👋 @Willeeuhmm! Not sure if our peds experience is of interest but our center recs cefazolin x 24 hr post-kidney transplant regardless of deceased or living donor. Donor or recipient cultures preceding may be taken into consideration. Looking forward to hearing other responses!
Question for #TxID#IDTwitter
Does your center provide different abx surg ppx recs for kidneys coming from deceased vs living donors? Ex pip tazo for deceased vs cefazolin for living. Also, any difference in duration of abx ppx (eg 48 vs <24 hrs) @TransplantIDNet@StanfordASP
🆕️🔥 Single centre cohort study @StanfordASP@bluPharmD@DHpharmd &🌟s*
In immunocompromised pts with Invasive Mucormycosis neither upfront nor salvage antifungal combo Rx was associated with a difference in 6 week mortality compared to monotherapy
https://t.co/wx4aEnv5Ot
“Race and ethnicity were determined by clinicians and were not self-reported”
-Paper published in JAMA
Genuinely curious how a clinician would make that determination 🤷🏽♂️